Assessment of pharmacokinetics and bioequivalence of amlodipine besylate in healthy volunteers
Yan Zhang
Abstract
Yan Zhang
Abstract
AIM: To study the pharmacokinetics parameters and bioavailability of amlodipine besylate tablets.METHODS: An open,randomized and two-period crossover study with a two-week washout interval was performed in 18 healthy volunteers.Concentrations of amlodipine besylate in plasma were assayed by liquid chromatographic-mass-mass spectrometric method after a single(oral) dose of 10 mg of the tested or the referenced tablets. The pharmacokinetics parameters,AUC,T_(max) and C_(max) were analyzed by two one-side t test and(1-2α) 90%.RESULTS: The main pharmacokinetics of the tested and referenced tablets were: T_(max):(8.9±2.5) and(8.2±2.2) h;C_(max):(5.1±2.3) and((5.0±)2.2) g/L;T_(1/2):(45±10) and(48±24) h;AUC_((0-120 h)):(191±69) and(196±53) μg/(L·h).The relative bioavailiability of amlodipine besylate was(99±23)%.(CONCLUSION:) The results of the statistical analysis show that the two formulations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To study the pharmacokinetics parameters and bioavailability of amlodipine besylate tablets.METHODS: An open,randomized and two-period crossover study with a two-week washout interval was performed in 18 healthy volunteers.Concentrations of amlodipine besylate in plasma were assayed by liquid chromatographic-mass-mass spectrometric method after a single(oral) dose of 10 mg of the tested or the referenced tablets. The pharmacokinetics parameters,AUC,T_(max) and C_(max) were analyzed by two one-side t test and(1-2α) 90%.RESULTS: The main pharmacokinetics of the tested and referenced tablets were: T_(max):(8.9±2.5) and(8.2±2.2) h;C_(max):(5.1±2.3) and((5.0±)2.2) g/L;T_(1/2):(45±10) and(48±24) h;AUC_((0-120 h)):(191±69) and(196±53) μg/(L·h).The relative bioavailiability of amlodipine besylate was(99±23)%.(CONCLUSION:) The results of the statistical analysis show that the two formulations are bioequivalent.
Key concepts: Bioequivalence, Pharmacokinetics, Amlodipine, Bioavailability, Crossover study, Pharmacology, Plasma concentration, Chromatography